Literature DB >> 1505660

The importance of triglycerides: results from the Prospective Cardiovascular Münster (PROCAM) Study.

G Assmann1, H Schulte.   

Abstract

In the PROCAM study hypertriglyceridaemia was much more common among men (18.6%) than women (4.2%). Prevalence increased with age in women, but remained nearly constant at about 20% in men aged 35 years or more. In a multiple regression analysis a strong negative correlation between triglycerides and HDL cholesterol was found. A positive relationship was observed with cholesterol, blood glucose, factor VIIc, and PAI-1 in both sexes. Only in men, triglycerides are positively correlated with Apo A-I, body mass index, cigarette smoking, and alcohol consumption. Postmenopausal women showed higher triglyceride levels than premenopausal women. No independent relationships were observed to age, blood pressure, Lp(a), Apo A-II, Apo B, AT-III, protein C, fibrinogen, and oral contraceptives. A longitudinal analysis of data from 4474 male PROCAM participants aged 40-64 years with a follow-up of 4 years did not identify triglycerides as an independent risk factor, but the data suggest hypertriglyceridaemia is an additional risk factor for CHD, when excessive triglycerides coincide with a high ratio of plasma cholesterol to HDL-cholesterol and with low HDL-cholesterol values.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1505660     DOI: 10.1007/bf00145359

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  21 in total

1.  SERUM LIPIDS DURING THE COURSE OF AN ACUTE MYOCARDIAL INFARCTION AND ONE YEAR AFTERWARDS.

Authors:  G TIBBLIN; K CRAMER
Journal:  Acta Med Scand       Date:  1963-10

2.  Serum triglycerides as an independent risk factor for death from coronary heart disease in middle-aged Norwegian men.

Authors:  A Tverdal; O P Foss; P Leren; I Holme; P G Lund-Larsen; K Bjartveit
Journal:  Am J Epidemiol       Date:  1989-03       Impact factor: 4.897

3.  Serum triglycerides in health and in ischemic heart disease.

Authors:  D F Brown; S H Kinch; J T Doyle
Journal:  N Engl J Med       Date:  1965-10-28       Impact factor: 91.245

4.  [Prediction and early diagnosis of coronary disease. Prospective epidemiologic study of industrial workers in Westphalia].

Authors:  G Assmann; W Oberwittler; H Schulte; H Schriewer; H Funke; P H Epping; W H Hauss
Journal:  Internist (Berl)       Date:  1980-08       Impact factor: 0.743

5.  Risk factors for ischaemic heart disease in men and women. Results of the 19-year follow-up of the Stockholm Prospective Study.

Authors:  L A Carlson; L E Böttiger
Journal:  Acta Med Scand       Date:  1985

6.  Changes in cholesterol and triglyceride as predictors of ischemic heart disease in men.

Authors:  R J Glynn; B Rosner; J E Silbert
Journal:  Circulation       Date:  1982-10       Impact factor: 29.690

7.  Relation of serum cholesterol and triglycerides to the risk of acute myocardial infarction, cerebral stroke and death in eastern Finnish male population.

Authors:  J T Salonen; P Puska
Journal:  Int J Epidemiol       Date:  1983-03       Impact factor: 7.196

8.  Serum triglycerides are a risk factor for myocardial infarction but not for angina pectoris. Results from a 10-year follow-up of Uppsala primary preventive study.

Authors:  H Aberg; H Lithell; I Selinus; H Hedstrand
Journal:  Atherosclerosis       Date:  1985-01       Impact factor: 5.162

9.  The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease.

Authors:  G Assmann; H Schulte
Journal:  Am Heart J       Date:  1988-12       Impact factor: 4.749

10.  Is the level of serum triglyceride a significant predictor of coronary death in "normocholesterolemic" subjects? The Paris Prospective Study.

Authors:  F Cambien; A Jacqueson; J L Richard; J M Warnet; P Ducimetiere; J R Claude
Journal:  Am J Epidemiol       Date:  1986-10       Impact factor: 4.897

View more
  7 in total

Review 1.  Clinical relevance of reducing triglycerides. Implications for ischaemic heart disease treatment.

Authors:  A N Nafziger
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

2.  NASH resolution is associated with improvements in HDL and triglyceride levels but not improvement in LDL or non-HDL-C levels.

Authors:  K E Corey; R Vuppalanchi; L A Wilson; O W Cummings; N Chalasani
Journal:  Aliment Pharmacol Ther       Date:  2014-11-28       Impact factor: 8.171

3.  Drug therapy for hypertriglyceridemia: fibrates and omega-3 fatty acids.

Authors:  Peter P Toth; Thomas D Dayspring; Gregory S Pokrywka
Journal:  Curr Atheroscler Rep       Date:  2009-01       Impact factor: 5.113

4.  Identification of patients at high risk for adverse coronary events while awaiting routine coronary angioplasty.

Authors:  M Chester; L Chen; J C Kaski
Journal:  Br Heart J       Date:  1995-03

Review 5.  Managing diabetic dyslipidemia: beyond statin therapy.

Authors:  Hemanth Neeli; Ram Gadi; Daniel J Rader
Journal:  Curr Diab Rep       Date:  2009-02       Impact factor: 4.810

Review 6.  Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease.

Authors:  Peter P Toth
Journal:  Vasc Health Risk Manag       Date:  2016-05-06

7.  Individuals with obesity but no other metabolic risk factors are not at significantly elevated all-cause mortality risk in men and women.

Authors:  J L Kuk; M Rotondi; X Sui; S N Blair; C I Ardern
Journal:  Clin Obes       Date:  2018-07-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.